Medication in the treatment of the behavioural sequelae of traumatic brain injury.
A significant proportion of children who sustain traumatic brain injury will go on to experience disturbance in their academic, emotional, and social functioning. There is a role for medication in the treatment of these late onset changes. This review will focus on the recognition and pharmacological treatment of the most common and most problematic presentations that may follow head injury, and supports the use of stimulant medication for secondary attention-deficit-hyperactivity disorder despite the small evidence base for use in children.
Bates
Gordon
G
Birmingham Children's Hospital, Parkview Clinic, Birmingham, UK. gordon.bates@bch.nhs.uk
D000293:Adolescent; D000342:Affective Symptoms / Q000188:drug therapy / Q000209:etiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000209:etiology; D001925:Brain Damage, Chronic / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D001930:Brain Injuries / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000188:drug therapy / Q000209:etiology; D001068:Feeding and Eating Disorders / Q000188:drug therapy / Q000209:etiology; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D009483:Neuropsychological Tests; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy / Q000209:etiology; D012893:Sleep Wake Disorders / Q000188:drug therapy / Q000209:etiology
D002491:Central Nervous System Agents; D006728:Hormones